BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance
Go back to BioMarin Pharma (BMRN) Tops Q1 EPS by 2c, Beats on Revenue; Offers FY26 EPS Guidance| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 65.62 +0.89 (1.37%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $64.73 | 52 Week High | $108.96 | |||
| Open | $65.34 | 52 Week Low | $62.12 | |||
| Day High | $66.21 | P/E | N/A | |||
| Day Low | $65.32 | EPS | $-1.27 | |||
| Volume | 281,683 | |||||
